Ignite Creation Date:
2024-05-05 @ 10:53 PM
Last Modification Date:
2024-10-26 @ 10:25 AM
Study NCT ID:
NCT01206933
Status:
COMPLETED
Last Update Posted:
2016-02-10
First Post:
2010-09-17
Brief Title:
The Effect of HIV Tat Protein on HCV Replication in an In-vitro Model System
Sponsor:
George Washington University
Organization:
George Washington University
Study Overview
Official Title:
The Effect of HIV Tat Protein on HCV Replication in an In-vitro Model System
Status:
COMPLETED
Status Verified Date:
2010-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Investigators in the Division of Infectious Diseases and the Departments of Biochemistry and Molecular Biology of The George Washington University Medical Center are carrying out a research study to determine why patients with Human Immunodeficiency Virus HIV and Hepatitis C virus HCV co-infection HIVHCV have a more rapid and progressive course of HCV infection leading to fatty infiltration of the liver and cirrhosis
Detailed Description:
Samples will be collected from 4 groups of patients with HIVHCV infection identified by the virologic control of either HIV HCV or both Sera will be used in an in-vitro hepatocyte model of hepatitis C infection to better understand the pathogenesis of HIVHCV co-infection and to gain insight into intracellular mechanisms
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None